The aim of this study was to explore the diagnostic and prognostic value of serum tumor M2‐pyruvate kinase (TuM2‐PK), neuron‐specific enolase (NSE), and progastrin‐releasing peptide (ProGRP) levels in patients with… Click to show full abstract
The aim of this study was to explore the diagnostic and prognostic value of serum tumor M2‐pyruvate kinase (TuM2‐PK), neuron‐specific enolase (NSE), and progastrin‐releasing peptide (ProGRP) levels in patients with small cell lung cancer (SCLC).
               
Click one of the above tabs to view related content.